Insider Transactions Reported by 13 Insiders of ImmunityBio, Inc.

Symbol
IBRX on Nasdaq
Location
San Diego, CA

There are no Buy or Sell transactions made by insiders since 25 Dec 2024

ImmunityBio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PATRICK SOON-SHIONG Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner $241M 22 Feb 2025
Barry J. Simon Director $11.2M 22 Feb 2025
Richard Adcock CEO & President, Director $2.19M 22 Feb 2025
John C. Thomas Former Director $1.09M 31 Dec 2021
David C. Sachs Chief Financial Officer $1.05M 22 Feb 2025
REGAN J. LAUER Chief Accounting Officer $405K 22 Feb 2025
LINDA MAXWELL Director 18 Jun 2025
Bruce Wendel Director 12 Dec 2025
Cheryl Cohen Director 18 Jun 2025
Christobel Selecky Director 18 Jun 2025
MICHAEL D. BLASZYK Director 18 Jun 2025
John Owen Brennan Director 11 Jun 2024
Wesley Clark Director 18 Jun 2025

Recent Insider Transactions by Companies or Individuals for ImmunityBio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.